Currently today, there is some 20% of world oil production under sanction. Take Iranian oil off the equation and it’s 25%. Trade economics had December crude production at 3.3 mil barrels per day.

Hims & Hers (HIMS) defends recovery with personalized healthcare adoption, GLP-1 partnerships, and profit growth. Click here ...

Novo Nordisk NVO shares have gained 5.8% in a week. The uptrend in the stock price was driven by reports of an activist hedge fund, Parvus Asset Management, building a stake in the company, as well ...

Patients taking the drugs are finding their families are benefiting, too. By Jackie Snow When Amy Kane started taking Mounjaro in 2022, she expected to lose weight — which she did, dropping more ...

Some GLP-1 users report "Ozempic smell," a newfound attraction to sweet perfumes and scents, possibly linked to how the medications affect the brain regions controlling smell and taste.

Ozempic may be adding some spring to your step — but it might also be taking a bite out of your smile. As the popularity of weight-loss drugs surges, a new concern is emerging: “Ozempic teeth ...

Let's start with the obvious: I didn't mean to overdose on Ozempic, and I don't recommend it.. But I did. It was one part grief brain, one part "I've got this," and about 2 milligrams of ...

What you eat. Fiber—predominantly found in beans, vegetables, whole grains, nuts and seeds—is the most notable nutrient that can significantly increase GLP-1.

New research has shown that Ozempic can cause taste changes in people taking it, even going so far as to make some hate the taste of meat. Click to Skip Ad Closing in ...

Citing the polling, the New York Post mentioned that Gen Z are the leaders in opting for weight loss medications to shed pounds instead of the traditional exercises and healthy diet.. Specifically ...

By staying active, exploring the wellness benefits of cannabis and CBD, and embracing the joy of movement, you can achieve a summer body that’s not only fit, but also balanced and resilient-no ...

Hims & Hers Health, Inc. teams up with Novo Nordisk to offer Wegovy at $599/month, slashing costs. Click for why this is a game-changing deal for HIMS stock.